Clinical trial
Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) and Sodium-glucose Cotransporter-2 Inhibitors (SGLT2is) Combination Therapy and Major Adverse Cardiovascular Events After Acute Myocardial Infarction: an Observational Study in Patients with Type 2 Diabetes.
NCT06017544 is registered in ClinicalTrials.gov with University of Campania Luigi Vanvitelli as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) and Sodium-glucose Cotransporter-2 Inhibitors (SGLT2is) Combination Therapy and Major Adverse Cardiovascular Events After Acute Myocardial Infarction: an Observational Study in Patients with Type 2 Diabetes.
- Lead sponsor
- University of Campania Luigi Vanvitelli
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2017
- Completion date
- December 1, 2024
- Enrollment
- 257 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.